Organigram Holdings Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, announced today that on August 30, 2024, the Company closed the second of three tranches (the "Second Tranche") of the previously announced C$124,559,674 follow-on strategic equity investment (the "Investment") by BT DE Investments Inc. (the "Investor"), a wholly owned subsidiary of British American Tobacco plc ("BAT"). Pursuant to the Second Tranche closing, the Investor acquired 4,429,740 common shares (the "Common Shares") and 8,463,435 Class A preferred shares (the "Preferred Shares" and together with the Common Shares, the "Shares") of the Company at a price of C$3

Net revenue of $41.1 million increased 25% over the prior year period Adjusted EBITDA1 of $3.5 million versus $(2.9) million over the prior year period Established European foothold with a strategic investment in Sanity Group, a leading German cannabis company Completed landmark clinical study on FAST™ nanoemulsion technology showing faster onset, improved bioavailability of ingestible products Pro-forma cash position of $173 million2 Organigram Holdings Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, announced its results for the third quarter ended June 30, 2024 ("Q3 Fiscal 2024"). THIRD QUARTER HIGHLIGHTS Third q

FAST™ Nanoemulsion Technology Expected to be a Competitive Advantage for Organigram's Ingestible Portfolio Organigram Holdings Inc. (NASDAQ:OGI) (TSX:OGI), a leading licensed producer of cannabis, is pleased to unveil the preliminary results of its landmark clinical pharmacokinetic (PK) study conducted via the Product Development Collaboration (PDC) on its latest innovation, nanoemulsion technology. This patent-pending technology, branded FAST™ (Fast Acting Soluble Technology), will be the first innovation to be commercialized by Organigram leveraging the output of the PDC*, a "Center of Excellence" established to focus on developing next-generation cannabis products. The clinical study

Organigram Holdings Inc. (NASDAQ:OGI) (TSX:OGI), the parent company of Organigram Inc. (together, the "Company" or "Organigram"), a leading licensed producer of cannabis, announced today it will report earnings results for its third quarter fiscal 2024 ended June 30, 2024, on Tuesday, August 13, 2024, prior to market open. The Company will host a conference call to discuss its results with details as follows: Date: Tuesday, August 13, 2024 Time: 8:00 am Eastern Time To register for the conference call, please use this link: https://registrations.events/direct/Q4I9676663358 To ensure you are connected for the full call, we suggest registering a day in advance or at minimum 10 minutes

Organigram Holdings Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, announced the appointment of Craig Harris to the Organigram Board of Directors effective today. Craig brings over 20 years of experience as a commercial lawyer, with a background in private practice and legal and regulatory engagement roles for various corporations. He is currently the Assistant General Counsel – Corporate & Commercial Legal at British American Tobacco plc (BAT). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240729497569/en/Craig Harris (Photo: Business Wire) "We are thrilled to welcome Cra

The partial third tranche investment is expected to enable Organigram to expand its product portfolio, addressing consumer demand for unique and differentiated aromas and flavours. This strategic funding supports the growth and diversification of Organigram's offerings with a view to enhancing its market position and appeal to consumers. Already a cultivation leader in high THCV cultivars, Organigram will now pilot higher potency rare cannabinoids such as CBG, CBC and CBDV. Organigram Holdings Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, announced today that it has completed an early partial funding of its final third tranc

Second "Jupiter" investment strengthens Organigram's European access, including to the high-growth market of Germany Highlights: Concurrent to the investment, Organigram and Sanity Group have entered into a new supply agreement to include significantly higher volumes and the intention to work together on the commercialization of Organigram's brands and intellectual property (IP) in Germany. Investment in the form of an unsecured convertible note combined with a minority equity stake in Sanity Group. Organigram entitled to appoint a representative to Sanity Group's Board of Directors. Organigram Holdings Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), a leading li

Over a three-year period, Organigram expects to supply 1,700 kilograms of high-quality medical cannabis flower to Avida Medical, with 500 kilograms expected to be delivered in the first year of the agreement. Avida Medical to become Organigram's second international medical cannabis customer in the UK. Organigram to grant Avida Medical strain exclusivity in the UK for three strains. To date, Organigram has established international supply agreements with a total of seven medical cannabis customers in Australia, Germany, Israel, and the UK, aligned to its strategy to extend its reach beyond Canada into global markets. Organigram Holdings Inc. (NASDAQ:OGI) (TSX:OGI), (the "Compan

21% growth in recreational net revenue year-over-year First Jupiter private placement tranche closed adding $41.5 million of cash bringing Organigram's closing cash balance at quarter-end to $83.6 million Subsequent to quarter end, closed $28.8 million oversubscribed marketed offering, which when combined with the remaining two anticipated Jupiter tranches will increase cash position by additional $110 million Company's recent investment in Steady State LLC (d/b/a Open Book Extracts) ("OBX") adds to growing U.S. portfolio, which includes Phylos Bioscience Inc. ("Phylos") Organigram's U.S.-based strategic investments may benefit from expected change in rescheduling of cannabis b

Organigram Holdings Inc. (NASDAQ:OGI) (TSX:OGI), the parent company of Organigram Inc. (together, the "Company" or "Organigram"), a leading licensed producer of cannabis, announced today it will report earnings results for its second quarter fiscal 2024 ended March 31, 2024, on Tuesday, May 14, 2024, prior to market open. The Company will host a conference call to discuss its results with details as follows: Date: Tuesday, May 14, 2024 Time: 8:00 am Eastern Time To register for the conference call, please use this link: https://registrations.events/direct/Q4I9676693302 To ensure you are connected for the full call, we suggest registering a day in advance or at minimum 10 minutes bef

SC 13D/A - ORGANIGRAM HOLDINGS INC. (0001620737) (Subject)

SC 13D/A - ORGANIGRAM HOLDINGS INC. (0001620737) (Subject)

SC 13D/A - ORGANIGRAM HOLDINGS INC. (0001620737) (Subject)

SC 13D/A - ORGANIGRAM HOLDINGS INC. (0001620737) (Subject)

SC 13G/A - ORGANIGRAM HOLDINGS INC. (0001620737) (Subject)

SC 13G/A - ORGANIGRAM HOLDINGS INC. (0001620737) (Subject)

SC 13D - ORGANIGRAM HOLDINGS INC. (0001620737) (Subject)

SC 13G/A - ORGANIGRAM HOLDINGS INC. (0001620737) (Subject)

Organigram Holdings Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, announced the appointment of Craig Harris to the Organigram Board of Directors effective today. Craig brings over 20 years of experience as a commercial lawyer, with a background in private practice and legal and regulatory engagement roles for various corporations. He is currently the Assistant General Counsel – Corporate & Commercial Legal at British American Tobacco plc (BAT). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240729497569/en/Craig Harris (Photo: Business Wire) "We are thrilled to welcome Cra

Organigram Holdings Inc. ("Organigram" or the "Company") (TSX:OGI) (NASDAQ:OGI), announced the appointment of Karina Gehring to the Organigram Board of Directors at the Company's annual general and special meeting held on January 18, 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240119151071/en/Karina Gehring (Photo: Business Wire) "We are thrilled to welcome Karina to our Board of Directors. Her extensive expertise in marketing and brand management combined with her ongoing experience with BAT will be a tremendous asset to our Board," said Peter Amirault, Board Chair, Organigram. Karina is one of two directors (includi

Organigram Holdings Inc. ("Organigram" or the "Company") (TSX:OGI) (NASDAQ:OGI) announced today the results of voting at its annual general and special meeting of shareholders (the "Shareholders") held virtually on January 18, 2024 (the "Meeting"). Election of Directors Each of the nine nominees listed in the Company's management information circular dated December 20, 2023 (the "Circular") provided in connection with the Meeting were elected as directors of the Company. The Company received proxies and virtual votes at the Meeting as set out below: Nominee # Votes For % of Votes For # Votes Against % of Votes Against Peter Amirault 21,048,219

Special Meeting to Approve $124.6 Million Investment from BAT at $3.2203/share and Creation of "Jupiter" Strategic Investment Pool Organigram Holdings Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, announced today that it has mailed and filed a management information circular (the "Circular") and related materials (the "Meeting Materials") for its annual and special meeting (the "Meeting") of the holders of its common shares (the "Shareholders") to be held on January 18, 2024. In addition to routine annual business to be conducted (including the election of directors and the appointment of an auditor), Shareholders at the Meeting wil

Organigram Holdings Inc. ("Organigram" or the "Company") (TSX:OGI) (NASDAQ:OGI) is pleased to announce that Greg Guyatt CPA, CA, formerly of Phoena Holdings Inc. ("Phoena"), has been appointed to the role of Chief Financial Officer effective January 8, 2024. Mr. Guyatt will lead Organigram's Finance and IT divisions and will report directly to Beena Goldenberg, Organigram's Chief Executive Officer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231218771633/en/Greg Guyatt (Photo: Business Wire) Mr. Guyatt is a seasoned financial executive with over 25 years of international public company and private equity backed company experi

Organigram Holdings Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, announces today that Ms. Caroline Ferland has resigned from the Board of Directors ("the Board") effective immediately. Ms. Ferland was a board member nominee appointed by BAT. "In her short time on the Board, Ms. Ferland made considerable contributions to Organigram," said Peter Amirault, Chair of Organigram's Board of Directors. "In addition to providing meaningful involvement on the strategic planning and corporate governance fronts, Ms. Ferland used her extensive international experience in legal and regulatory matters to support the Company, providing solid strat

FN Media Group Presents Microsmallcap.com Market Commentary NEW YORK, Aug. 23, 2022 /PRNewswire/ -- The CBD oil market is expected to witness an astounding CAGR of 38.90% from 2021 until 2029, climbing from $9.86 billion to $136.64 billion. There are several reasons behind the projected growth such a growing number of CBD-infused skincare products, increased use of THC and CBD in pain management and treatment, rising sales in both retail stores and online, expanding research, and increasing demand for ingestible products. Governments around the world have also begun opening up more doors for CBD, with a recent Health Canada report suggesting legal framework to broaden retail CBD sales across

Organigram Holdings Inc. ("Organigram" or the "Company") (TSX:OGI) (NASDAQ:OGI), the parent company of Organigram Inc., a leading Canadian producer of cannabis, is pleased to announce Beena Goldenberg, formerly Chief Executive Officer of The Supreme Cannabis Company Inc. and previously Chief Executive Officer at Hain-Celestial Canada, ULC, has been appointed the Company's new Chief Executive Officer (CEO). Ms. Goldenberg will assume the role effective September 9, 2021. An accomplished business leader, Ms. Goldenberg has more than 30 years of experience in consumer-packaged goods, manufacturing and marketing. As President and CEO of The Supreme Cannabis Company Inc., she successfully achie

Organigram Holdings Inc. ("Organigram" or the "Company") (TSX:OGI) (NASDAQ:OGI), the parent company of Organigram Inc., a leading producer of cannabis, is pleased to announce the appointment of Megan McCrae as the Company's Senior Vice President of Marketing and Communications. Ms. McCrae will assume her new role effective today. A seasoned marketing expert, Ms. McCrae has 17 years experience in consumer packaged goods marketing and sales management, brand building and consumer insights. Ms. McCrae is a cannabis industry veteran, having most recently served as Chief Marketing Officer of Aphria Inc. where she led the company's brand and product strategy including brand and portfolio manage

Organigram Holdings Inc. ("Organigram" or the "Company") (TSX:OGI) (NASDAQ:OGI), the parent company of Organigram Inc., a leading producer of cannabis, is pleased to announce the appointment of Borna Zlamalik as the Company's Vice President of Innovation. Mr. Zlamalik will assume his new role effective today. In his new role, Mr. Zlamalik will draw upon his international expertise in cannabis and cannabinoid-based product advancement, commercialization, and pricing strategy to direct consumer product innovation. As the Company's Vice President, Innovation, Mr. Zlamalik will oversee all R&D and product development. He will also sit as one of Organigram's representatives on the Steering Comm

Net revenue of $41.1 million increased 25% over the prior year period Adjusted EBITDA1 of $3.5 million versus $(2.9) million over the prior year period Established European foothold with a strategic investment in Sanity Group, a leading German cannabis company Completed landmark clinical study on FAST™ nanoemulsion technology showing faster onset, improved bioavailability of ingestible products Pro-forma cash position of $173 million2 Organigram Holdings Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, announced its results for the third quarter ended June 30, 2024 ("Q3 Fiscal 2024"). THIRD QUARTER HIGHLIGHTS Third q

Organigram Holdings Inc. (NASDAQ:OGI) (TSX:OGI), the parent company of Organigram Inc. (together, the "Company" or "Organigram"), a leading licensed producer of cannabis, announced today it will report earnings results for its third quarter fiscal 2024 ended June 30, 2024, on Tuesday, August 13, 2024, prior to market open. The Company will host a conference call to discuss its results with details as follows: Date: Tuesday, August 13, 2024 Time: 8:00 am Eastern Time To register for the conference call, please use this link: https://registrations.events/direct/Q4I9676663358 To ensure you are connected for the full call, we suggest registering a day in advance or at minimum 10 minutes

21% growth in recreational net revenue year-over-year First Jupiter private placement tranche closed adding $41.5 million of cash bringing Organigram's closing cash balance at quarter-end to $83.6 million Subsequent to quarter end, closed $28.8 million oversubscribed marketed offering, which when combined with the remaining two anticipated Jupiter tranches will increase cash position by additional $110 million Company's recent investment in Steady State LLC (d/b/a Open Book Extracts) ("OBX") adds to growing U.S. portfolio, which includes Phylos Bioscience Inc. ("Phylos") Organigram's U.S.-based strategic investments may benefit from expected change in rescheduling of cannabis b

Organigram Holdings Inc. (NASDAQ:OGI) (TSX:OGI), the parent company of Organigram Inc. (together, the "Company" or "Organigram"), a leading licensed producer of cannabis, announced today it will report earnings results for its second quarter fiscal 2024 ended March 31, 2024, on Tuesday, May 14, 2024, prior to market open. The Company will host a conference call to discuss its results with details as follows: Date: Tuesday, May 14, 2024 Time: 8:00 am Eastern Time To register for the conference call, please use this link: https://registrations.events/direct/Q4I9676693302 To ensure you are connected for the full call, we suggest registering a day in advance or at minimum 10 minutes bef

Achieved positive cash flow from operations, solidified #2 market position in Canada among licensed producers, significantly improved margins sequentially quarter-over-quarter, and closed first $41.5 million tranche of previously announced $124.6 million investment from BAT HIGHLIGHTS $124.6 million strategic investment from BAT announced in November 2023 approved by shareholders, with first of three tranches now funded at $3.22 per share for proceeds of $41.5 million Achieved positive Adjusted EBITDA1 and positive cash flow from operations of $7.7 million Improved sequential quarter-over-quarter adjusted gross margin2 from 17% in Q4 Fiscal 2023 (references to "Fiscal 2023" are t

Organigram Holdings Inc. (NASDAQ:OGI) (TSX:OGI), the parent company of Organigram Inc. (together, the "Company" or "Organigram"), a leading licensed producer of cannabis, announced today it will report earnings results for its first quarter fiscal 2024 ended December 31, 2023, on Tuesday, February 13, 2024, prior to market open. The Company will host a conference call to discuss its results with details as follows: Date: Tuesday, February 13, 2024 Time: 8:00 am Eastern Time To register for the conference call, please use this link: https://registrations.events/direct/Q4I967666846597333509997000 To ensure you are connected for the full call, we suggest registering a day in advance or

Domestic share growth in several key categories continues to be driven by innovation excellence and industry-leading R&D. Organigram continues to take a leadership position in industry fighting THC mislabelling (inflation). Company fortifying itself with recently announced BAT-Jupiter $124.6 million private placement transaction strengthening balance sheet and setting the stage for long-term growth outside of Canada. FISCAL 2023 HIGHLIGHTS At year-end, achieved the #2 position among Canadian licensed producers driven by success of growing pre-roll business2 Held the #1 position in the milled flower, gummies, and hash categories2 Held the #3 market position in Ontario, #3

Organigram Holdings Inc. (NASDAQ:OGI) (TSX:OGI), the parent company of Organigram Inc. (together, the "Company" or "Organigram"), a leading licensed producer of cannabis, announced today it will report earnings results for its fourth quarter and fiscal 2023 ended September 30, 2023, on Tuesday, December 19, 2023, before market open. The Company will host a conference call to discuss its results with details as follows: Date: Tuesday, December 19, 2023 Time: 8:00 am Eastern Time To register for the conference call, please use this link: https://conferencingportals.com/event/XWQpOvKk To ensure you are connected for the full call, we suggest registering a day in advance or at minimum 1

Year-to-date Canadian recreational business grew 10% versus prior year driven by continued focus on consumer-centric products and brands Strategic investments in Phylos and Greentank strengthen Organigram's position as an industry leader in cannabis innovation, solidifying long-term competitive advantage HIGHLIGHTS Recreational net revenue was $92.5 million for the nine months ended May 31, 2023, an increase of $8.0 million over the same prior-year period Increased sequential net revenue from Canadian recreational business by 7% vs. Q2 driven by continued success in hash and rebound in flower Organigram regained the #3 position in May and held it through June with 6.7% nation

Organigram Holdings Inc. (NASDAQ:OGI) (TSX:OGI), the parent company of Organigram Inc. (together, the "Company" or "Organigram"), a leading licensed producer of cannabis, announced today it will report earnings results for its third quarter fiscal 2023 ended May 31, 2023, on Thursday, July 13, 2023, after market close. The Company will host a conference call to discuss its results with details as follows: Date: Friday, July 14, 2023 Time: 8:00 am Eastern Time To register for the conference call, please use this link: https://conferencingportals.com/event/RUyBPhzX To ensure you are connected for the full call, we suggest registering a day in advance or at minimum 10 minutes before

The cannabis sector witnessed significant movement today, with varied performances across key stocks and ETFs following President Joe Biden’s Sunday announcement that he will not seek re-election. The news created ripples in the market, reflecting investor sentiment and speculation about future regulatory changes. Biggest Winners Aurora Cannabis (NASDAQ:ACB): Increased by 9.04% to $6.02. Positive sentiment is driven by strategic partnerships. Village Farms International (NASDAQ:VFF): Rose by 7.41% to $1.09. The stock benefited from operational efficiency news. Tilray Brands (NASDAQ:TLRY): Saw a rise of 6.70% to $1.87. Investor optimism on future growth prospects in Germany. SNDL (NASD

GAINERS: Leafbuyer Techs (OTC:LBUY) shares closed up 3900.00% at $0.02 Heritage Cannabis Holding (OTC:HERTF) shares closed up 125.00% at $0.00 AusCann Group Holdings (OTC:ACNNF) shares closed up 50.00% at $0.01 Cann Gr (OTC:CNGGF) shares closed up 37.50% at $0.02 Target Group (OTC:CBDY) shares closed up 30.59% at $0.00 Canopy Gwth (NASDAQ:CGC) shares closed up 17.25% at $8.35 RIV Capital (OTC:CNPOF) shares closed up 13.33% at $0.10 GrowGeneration (NASDAQ:GRWG) shares closed up 13.03% at $2.66 Auxly Cannabis Group (OTC:CBWTF) shares closed up 12.60% at $0.03 SNDL (NASDAQ:SNDL) shares closed up 9.66% at $2.27 Aurora Cannabis (NASDAQ:ACB) shares closed up 8.87% at $6.25 Village Farms Intl (NAS

President Joe Biden's announcement that he will not seek re-election has impacted the cannabis stock market. The sector's reaction varied, reflecting investor sentiment and market speculation about future regulatory changes under a potential new administration. This analysis, derived from Benzinga Pro data, highlights the key movements among popular cannabis stocks 24 hours after the announcement. Biggest Losers Several cannabis stocks faced a downturn following the announcement. Curaleaf Holdings (OTC:CURLF) decreased by 1.3986% to $4.23. Jushi Holdings (OTC:JUSHF) dropped by 5.0847%, reaching $0.56. Green Thumb Industries (OTC:GTBIF) fell by 2.3444% to $11.455. Trulieve Cannabis (OTC:TCN

GAINERS: Green Growth Brands (OTC:GGBXF) shares closed up 9900.00% at $0.0001 Rocky Mountain High (OTC:RMHB) shares closed up 33.33% at $0.02 SOL Glb Inv (OTC:SOLCF) shares closed up 19.57% at $0.05 Affinor Growers (OTC:RSSFF) shares closed up 19.12% at $0.08 Pharmadrug (OTC:LMLLF) shares closed up 18.52% at $0.02 1933 Industries (OTC:TGIFF) shares closed up 8.23% at $0.01 Cansortium (OTC:CNTMF) shares closed up 7.14% at $0.15 CV Sciences (OTC:CVSI) shares closed up 7.12% at $0.06 CLS Holdings USA (OTC:CLSH) shares closed up 6.26% at $0.04 Cipher Pharmaceuticals (OTC:CPHRF) shares closed up 5.67% at $6.43 Body and Mind (OTC:BMMJ) shares closed up 5.40% at $0.03 OrganiGram Holdings (NASDAQ:O

Canaccord Genuity analyst Yewon Kang assumes OrganiGram Holdings (TSX:OGI) with a Speculative Buy rating and announces Price Target of C$3.25.

Analyst Lorimer Wilson, a contributor at TalkMarkets, signaled that Canadian Limited Partnership (LPs) Cannabis Companies did much better than American multi-state operators (MSOs) as the cannabis sector remains highly volatile, with stock prices reacting sharply to news. Canadian Cannabis Outperforms Canadian Cannabis LPs doubled the performance of cannabis companies from the US. The Canadian Cannabis LP Portfolio saw significant gains: Aurora Cannabis (NASDAQ:ACB): UP 24.7% this week; UP 30.1% MTD; UP 27.3% YTD Tilray Brands (NASDAQ:TLRY): UP 8.7% this week; UP 13.3% MTD; DOWN 18.3% YTD Cronos Group (NASDAQ:CRON): UP 8.1% this week; UP 3.4% MTD; UP 15.3% YTD Organigram

GAINERS: Australis Capital (OTC:AUSAF) shares closed up 9900.00% at $0.0001 Cara Therapeutics (NASDAQ:CARA) shares closed up 25.84% at $0.37 4Front Ventures (OTC:FFNTF) shares closed up 23.42% at $0.10 Cannabix Technologies (OTC:BLOZF) shares closed up 15.92% at $0.43 Global Compliance (OTC:FUAPF) shares closed up 12.75% at $0.01 22nd Century Group (NASDAQ:XXII) shares closed up 11.92% at $0.79 Curaleaf Holdings (OTC:CURLF) shares closed up 9.71% at $4.18 SOL Glb Inv (OTC:SOLCF) shares closed up 9.05% at $0.04 OrganiGram Holdings (NASDAQ:OGI) shares closed up 7.59% at $1.70 RIV Capital (OTC:CNPOF) shares closed up 7.14% at $0.10 GrowGeneration (NASDAQ:GRWG) shares closed up 6.82% at $2.35 A

On July 10, Zuanic & Associates hosted a panel discussion focusing on the European cannabis market, featuring Benna Goldenberg, CEO of Organigram Holdings (NASDAQ:OGI), and Finn Age Hansel, CEO of Sanity Group. Senior analyst Pablo Zuanic led the discussion, which centered on the companies' strategies for expanding in Germany and the broader European market. Organigram's Strategic Move In Germany Organigram has been actively expanding its presence in the international markets, with a particular focus on Germany. And, according to CEO Benna Goldenberg, the company's partnership with Sanity Group is a key element in this strategy. The collaboration is bolstered by British American Tobacco (

GAINERS: Heritage Cannabis Holding (OTC:HERTF) shares closed up 66.67% at $0.001 Global Compliance (OTC:FUAPF) shares closed up 31.39% at $0.01 Global Hemp Group (OTC:GBHPF) shares closed up 29.87% at $0.03 Zelira Therapeutics (OTC:ZLDAF) shares closed up 21.73% at $0.23 4Front Ventures (OTC:FFNTF) shares closed up 14.45% at $0.08 Greenlane Hldgs (NASDAQ:GNLN) shares closed up 13.74% at $0.27 MariMed (OTC:MRMD) shares closed up 9.94% at $0.19 Zoned Props (OTC:ZDPY) shares closed up 9.91% at $0.66 iAnthus Capital Hldgs (OTC:ITHUF) shares closed up 8.82% at $0.02 Aurora Cannabis (NASDAQ:ACB) shares closed up 8.42% at $4.90 Emeren Group (NYSE:SOL) shares closed up 7.14% at $1.62 OrganiGram Hol

GAINERS: Kaya Holdings (OTC:KAYS) shares closed up 154.44% at $0.04 Heritage Cannabis Holding (OTC:HERTF) shares closed up 66.67% at $0.001 Global Compliance (OTC:FUAPF) shares closed up 31.39% at $0.01 Global Hemp Group (OTC:GBHPF) shares closed up 29.87% at $0.03 Zelira Therapeutics (OTC:ZLDAF) shares closed up 21.73% at $0.23 4Front Ventures (OTC:FFNTF) shares closed up 14.45% at $0.08 Cansortium (OTC:CNTMF) shares closed up 13.27% at $0.12 MariMed (OTC:MRMD) shares closed up 9.94% at $0.19 Zoned Props (OTC:ZDPY) shares closed up 9.91% at $0.66 Aurora Cannabis (NASDAQ:ACB) shares closed up 8.42% at $4.90 OrganiGram Holdings (NASDAQ:OGI) shares closed up 6.04% at $1.59 Greenlane Hldgs (NA